Related by context. All words. (Click for frequent words.) 78 5-FU/LV 77 FOLFOX 74 FOLFOX4 74 FOLFIRI 74 carboplatin paclitaxel 73 Folfox 72 plus dexamethasone 72 chlorambucil 72 low dose cytarabine 71 pegylated interferon alfa 2b 71 5FU 71 infusional 5-FU/LV 71 cisplatin vinorelbine 71 sorafenib Nexavar 71 pegylated liposomal doxorubicin 71 Peg IFN 70 standard chemotherapy regimen 70 Fludara 70 Xelox 70 Taxotere ® 70 gemcitabine carboplatin 70 Irinotecan 70 DOXIL 70 mycophenolate mofetil 70 low dose dexamethasone 70 comparator arm 70 mCRC patients 70 dacarbazine 70 DMARD 69 decitabine 69 gemcitabine chemotherapy 69 Flu Cy 69 FluCAM 69 Elitek 69 placebo dexamethasone 69 Paraplatin ® 69 telaprevir dosed 69 docetaxel chemotherapy 69 fluorouracil 69 FOLPI 69 chemoradiation therapy 69 daunorubicin 69 Adjuvant chemotherapy 69 bicalutamide 69 irbesartan 69 fludarabine 68 goserelin 68 CIMZIA TM 68 Gemcitabine 68 oblimersen 68 Capecitabine 68 clodronate 68 fluvastatin 68 preoperative chemotherapy 68 capecitabine Xeloda 68 pCR 68 ELOXATIN 68 anastrozole 68 mitoxantrone 68 ABVD 68 bevacizumab Avastin 68 trabectedin 68 idraparinux 68 docetaxel prednisone 68 Doxil ® 68 adriamycin 68 CR nPR 68 mRCC 68 rizatriptan 68 FOLFIRI alone 68 eribulin 68 capecitabine 67 fluoropyrimidine 67 pemetrexed 67 neoadjuvant therapy 67 peginterferon alfa 2b 67 neoadjuvant chemotherapy 67 oral Xeloda 67 Lenalidomide 67 oral diclofenac 67 abciximab 67 cabazitaxel 67 bendamustine 67 eplerenone 67 azacitidine 67 galiximab 67 dasatinib 67 vinorelbine 67 ABC/3TC 67 plus prednisone 67 chemoradiotherapy 67 chemotherapy FOLFOX 67 Pemetrexed 67 adjuvant chemotherapy 67 zoledronic acid 67 erlotinib Tarceva ® 67 RLAI 67 lopinavir r 67 adjuvant tamoxifen 67 Gemzar ® 67 interferon alfa 2b 67 chemoradiation 67 cetuximab 67 topotecan 67 adjuvant radiotherapy 67 TAXOTERE R 67 Xeloda ® 67 doxazosin 67 BEACOPP 67 relapsed MM 67 Trastuzumab 66 chemotherapy docetaxel 66 flutamide 66 mapatumumab 66 chemotherapy cisplatin 66 sunitinib 66 estramustine 66 docetaxel Taxotere 66 postoperative chemotherapy 66 salmeterol fluticasone 66 pegylated interferon alfa 66 CHOP chemotherapy 66 Erlotinib 66 mg/m2 dose 66 adecatumumab 66 methotrexate monotherapy 66 interferon alfa 66 interferon alfa 2a 66 CIMZIA ™ 66 stage IIIb IV 66 pertuzumab 66 dose dexamethasone 66 pamidronate 66 MAGE A3 ASCI 66 TORISEL 66 KRAS wild 66 Torisel 66 #mg BID [001] 66 Bevacizumab 66 neoadjuvant 66 Median PFS 66 squamous histology 66 azathioprine 66 Free Survival PFS 66 pegylated interferon alpha 66 mg kg dose 66 peginterferon alfa 2a 66 sunitinib malate 66 LPV r 66 tamsulosin 66 trastuzumab 66 KRAS mutations occur 66 ARIMIDEX 66 tenofovir emtricitabine 66 paclitaxel carboplatin 66 oxaliplatin Eloxatin 66 exemestane 66 amoxicillin clavulanate 66 oxaliplatin 66 Targretin 66 docetaxel Taxotere R 66 gemcitabine 66 CANCIDAS 66 gemcitabine Gemzar 66 docetaxel 66 vandetanib 66 tiotropium 66 dacarbazine chemotherapy 66 temsirolimus 66 5 FU leucovorin 66 relapsed SCLC 66 ACTEMRA TM 66 dacarbazine DTIC 65 DMARDs 65 APTIVUS r 65 metastatic malignant 65 efavirenz EFV 65 plus gemcitabine 65 trastuzumab Herceptin ® 65 dalteparin 65 Pertuzumab 65 fondaparinux 65 stage IIIB 65 relapsed refractory multiple myeloma 65 metastatic castration resistant 65 unfractionated heparin 65 irinotecan chemotherapy 65 Neoadjuvant 65 IFN alfa 65 K ras mutations 65 Bezielle 65 LEXIVA r 65 KRAS status 65 metastatic hormone refractory 65 ritonavir boosted 65 Hycamtin 65 imipenem 65 metastatic renal cell carcinoma 65 Paraplatin ® carboplatin 65 tamoxifen therapy 65 Pegylated Liposomal Doxorubicin 65 gefitinib Iressa 65 Peginterferon 65 tocilizumab 65 oral clodronate 65 posaconazole 65 glatiramer acetate 65 FOLFOX regimen 65 Jevtana 65 Natalizumab 65 alfa 2a 65 iniparib BSI 65 aspirin clopidogrel 65 Fludarabine 65 DMARDS 65 Aptivus ® 65 abacavir lamivudine 65 aflibercept 65 trastuzumab Herceptin R 65 FOLFOX6 65 Exemestane 65 nab paclitaxel 65 stavudine d4T 65 DAPT 65 docetaxel Taxotere ® 65 infliximab monotherapy 65 lymphadenectomy 65 folinic acid 65 BRIM2 65 Herceptin trastuzumab 65 pazopanib 65 cyclophosphamide methotrexate 65 bortezomib 65 axitinib 65 Fulvestrant 65 temozolomide 65 ribavirin RBV 65 TYKERB 65 locoregional recurrence 65 Xeloda capecitabine 65 melphalan prednisone 65 unresectable stage 65 bevacizumab Avastin ® 65 unfractionated heparin UFH 65 IRESSA 65 pomalidomide 65 ZOLINZA 65 eptifibatide 65 5-fluorouracil/leucovorin 65 SPRYCEL ® 65 Ranolazine 65 ULORIC 65 neoadjuvant treatment 65 cisplatin gemcitabine 65 ARIXTRA 64 Cytoxan 64 ATACAND 64 PegIFN RBV 64 FASLODEX 64 doxorubicin docetaxel 64 degarelix 64 boosted protease inhibitor 64 Epirubicin 64 sorafenib tablets 64 highly emetogenic 64 sustained virologic response 64 AVASTIN 64 VELCADE melphalan 64 seliciclib 64 #mg dose [003] 64 xanthine oxidase inhibitor 64 complete cytogenetic response 64 Hazard Ratio 64 AVODART 64 paclitaxel Taxol ® 64 sorafenib 64 ritonavir boosted atazanavir 64 oxycodone CR 64 azacytidine 64 HER2 positive metastatic breast 64 eribulin mesylate 64 metastatic CRC 64 fluticasone salmeterol 64 trastuzumab Herceptin 64 teriflunomide 64 MGd 64 candesartan cilexetil 64 nadolol 64 vorinostat 64 sorafenib Nexavar ® 64 cisplatin chemotherapy 64 Cetuximab 64 Navelbine 64 5 fluorouracil leucovorin 64 oral rivaroxaban 64 antiandrogen 64 oral FTY# 64 FIRMAGON 64 epirubicin 64 Thal Dex 64 Platinol ® cisplatin 64 relapsed ovarian cancer 64 glargine 64 adjunctive placebo 64 PREZISTA r 64 erlotinib 64 biliary tract cancer 64 cediranib 64 dose cytarabine 64 ribavirin therapy 64 atorvastatin #mg 64 adjuvant radiation 64 sargramostim 64 Pegylated interferon 64 μmol L 64 EFAPROXYN 64 Campath alemtuzumab 64 titrated glipizide 64 CYPHER Stent 64 Interferon alfa 64 partial remissions 64 CoFactor 64 enzastaurin 64 achieved CCyR 64 lenalidomide Revlimid R 64 Halaven 64 bevacizumab 64 metastatic RCC 64 regorafenib 64 virologic response 64 concurrent chemoradiation 64 metastatic GIST 64 Peginterferon Alfa 2a 64 Camptosar ® 64 overlapping toxicities 64 Platinol 64 virologic failure 64 nodular partial response 64 anastrazole 64 metastatic HRPC 64 enalapril 64 CCyR 64 adalimumab 64 Aflibercept 64 Dasatinib 64 oral allopurinol 64 divalproex sodium 64 dasatinib Sprycel 64 ARB telmisartan 64 colesevelam HCl 64 DEB# 64 YONDELIS 64 letrozole 64 Mylotarg 64 sirolimus stent 64 remission CR 64 atazanavir ritonavir 64 iniparib 64 certolizumab 64 Hormone Refractory Prostate Cancer 64 debulking surgery 64 recurrent NSCLC 64 paclitaxel Taxol 64 cilostazol 64 assessing T DM1 64 achieved ACR# 64 oral chemotherapeutic agent 64 GnRH agonists 64 interferon therapy 64 tipranavir 64 mg QD 64 EGFR TKI 64 thalidomide Thalomid 64 NEVO ™ 64 gefitinib 64 idarubicin 64 NPH insulin 64 YERVOY 64 everolimus eluting stents 64 Engerix B 64 erlotinib Tarceva 64 sipuleucel T 64 XIENCE V PROMUS Stent 64 Pegylated Interferon 64 PegIFN 64 uric acid lowering 64 Betaferon ® 64 darunavir ritonavir 64 DOXIL ® 64 Combination therapy 64 ritonavir boosted lopinavir 64 octreotide LAR 64 valsartan 64 bevacizumab Avastin R 63 4mg/kg 63 TAXUS Express Stent 63 imatinib Gleevec 63 long acting bronchodilator 63 neurologic progression 63 FOLFOX4 alone 63 protease inhibitor PI 63 HER2 overexpression 63 oral ridaforolimus 63 Hycamtin ® 63 BARACLUDE ® 63 gemcitabine cisplatin 63 calcineurin inhibitors 63 alteplase 63 VIRAMUNE 63 doxorubicin cyclophosphamide 63 TELCYTA 63 saline placebo 63 unresectable 63 β blockers 63 Kaplan Meier analysis 63 refractory chronic lymphocytic 63 ethambutol 63 metformin sulfonylurea 63 NATRECOR R 63 VFEND 63 biochemical relapse 63 alpha 2a 63 TDF FTC 63 rFSH 63 #mg BID [003] 63 levosimendan 63 benazepril 63 IFN α 63 Copegus ribavirin 63 recurrent metastatic 63 genotypic resistance 63 EBRT 63 free survival PFS 63 BENICAR HCT 63 Taxol ® 63 COPEGUS 63 cytarabine daunorubicin 63 lenalidomide dexamethasone 63 BCIRG 63 Velcade bortezomib 63 advanced adenomas 63 IFN beta 63 androgen suppression 63 ZACTIMA 63 peginterferon 63 leukemia AML 63 Cloretazine 63 Navelbine ® 63 #mg doses [002] 63 recurrent glioblastoma multiforme 63 locoregional 63 elotuzumab 63 Taxotere 63 insulin glargine 63 pyridostigmine 63 interferon gamma 1b 63 biologic DMARD 63 entecavir 63 platinum refractory 63 mcg albinterferon alfa 2b 63 rosuvastatin #mg 63 rFVIIa 63 IIIa inhibitor 63 Fluorouracil 63 afatinib 63 sevelamer 63 abatacept 63 iodixanol 63 oral Hycamtin 63 tamoxifen Nolvadex ® 63 preoperative radiotherapy 63 bosentan 63 KRAS mutations 63 Bortezomib 63 R# #mg BID 63 methotrexate therapy 63 Ixempra 63 PEG IFN 63 active comparator 63 HCV SPRINT 63 angiotensin converting enzyme inhibitor 63 paclitaxel eluting stents 63 anthracycline taxane 63 Temsirolimus 63 interferon ribavirin 63 multicentre randomized 63 letrozole Femara 63 tirofiban 63 insulin glulisine 63 STRIDE PD 63 bleomycin 63 DMARD therapy 63 cetuximab Erbitux 63 TACE 63 zoledronate 63 allogeneic SCT 63 ZYVOX 63 cetuximab Erbitux R 63 leucovorin 63 tenecteplase 63 liver metastasis 63 carboplatin chemotherapy 63 Dabigatran 63 Alkeran 63 SCCHN 63 chlorthalidone 63 Subgroup analysis 63 Tarceva TM 63 APTIVUS 63 abiraterone acetate 63 Platinol ® 63 custirsen 63 5 fluorouracil 63 bivalirudin 63 hydroxychloroquine 63 paclitaxel cisplatin 63 Nexavar sorafenib 63 chemoembolization 63 3TC lamivudine Epivir 63 antitumor effect 63 cinacalcet 63 adalimumab Humira 63 Tarceva erlotinib 63 oral antidiabetic 63 metastatic castrate resistant 63 receiving VICTRELIS 62 nicardipine 62 insulin detemir 62 XYOTAX TM 62 FOLFOX chemotherapy 62 PEGINTRON TM 62 sunitinib Sutent 62 sulphonylureas 62 Elotuzumab 62 Neulasta ® 62 AZT zidovudine Retrovir 62 micafungin 62 radical nephrectomy 62 Carboplatin 62 Adjuvant Treatment 62 TTF Therapy 62 amrubicin 62 CsA 62 adjuvant trastuzumab 62 hepatic metastases 62 tigecycline 62 5 Fluorouracil 62 bosutinib 62 fluorouracil leucovorin 62 recurrent GBM 62 refractory AML 62 NCCTG N# 62 COPAXONE R 62 crizotinib PF # 62 fulvestrant 62 ORENCIA ® 62 androgen deprivation 62 endometrial hyperplasia 62 tesmilifene 62 TNF inhibitor 62 Bivalirudin 62 febuxostat 62 pioglitazone HCl 62 antiemetic 62 pioglitazone 62 RoACTEMRA 62 HCV genotype 62 refractory multiple myeloma 62 clopidogrel Plavix 62 Femara letrozole 62 platelet inhibitor 62 NNRTI resistance 62 HBeAg negative 62 HBeAg negative patients 62 CRp 62 herpetic keratitis 62 TAXUS Stent 62 ancrod 62 NSABP B 62 olaparib 62 remission induction 62 GnRH agonist 62 nitazoxanide 62 peg IFN 62 perioperatively 62 viral kinetics 62 standard chemotherapy regimens 62 paricalcitol 62 tanespimycin 62 lopinavir r arm 62 candesartan 62 heavily pretreated patients 62 dose clopidogrel 62 liposomal doxorubicin 62 leflunomide 62 splenectomized patients 62 pegylated liposomal doxorubicin PLD 62 serum urate 62 nondiabetic patients 62 conventional angiography 62 EndoTAGTM 1 62 metastatic malignant melanoma 62 icatibant 62 trabedersen 62 EBMT criteria 62 median PFS 62 #.#mg/dL 62 intravenous bisphosphonates 62 cetuximab Erbitux ® 62 aldosterone antagonists 62 Gliadel Wafer 62 q8h 62 achieved sustained virological 62 glulisine 62 TroVax ® 62 bezafibrate 62 underwent surgical resection 62 pneumonectomy 62 moderate renal impairment 62 Azacitidine 62 pegylated interferon alpha 2a 62 HBeAg seroconversion 62 PEGylated Fab fragment 62 d4T 62 prednisone prednisolone 62 fibrinolytic therapy 62 lispro 62 OPAXIO 62 doxorubicin HCl liposome injection 62 TEMODAL 62 AEGR 62 gadobutrol 62 cytotoxic chemotherapy 62 Pegasys ® 62 mitoxantrone chemotherapy 62 CAELYX 62 FOLFIRINOX 62 Taxol paclitaxel 62 tinidazole 62 Aromasin 62 prostate cancer HRPC 62 NXL# 62 dexamethasone Decadron 62 Oxaliplatin 62 teriparatide 62 desvenlafaxine succinate 62 steroid dexamethasone 62 alkylating agent 62 antiangiogenic therapy 62 receptor tyrosine kinase inhibitor 62 pegfilgrastim 62 lapatinib Tykerb 62 Neupogen ® 62 VIDAZA 62 salmeterol fluticasone propionate 62 Procoralan 62 nonmetastatic 62 Peginterferon alfa 2b 62 randomized multicenter Phase III 62 heavily pretreated 62 malignant pleural mesothelioma 62 rimonabant #mg 62 PegIntron 62 Ramipril 62 FUSILEV enhances 62 Carvedilol 62 APTIVUS R 62 curative resection 62 biochemical recurrence 62 fallopian tube carcinoma 62 Diovan HCT 62 elacytarabine 62 Vidaza ® 62 chemotherapeutic regimens 62 systemic corticosteroid 62 Soft Tissue Sarcoma 62 cilengitide 62 Amrubicin 62 olmesartan 62 Taxus Stent 62 lamivudine 62 sleeve lobectomy 62 tibolone 62 ceftazidime 62 ezetimibe simvastatin 62 Tesmilifene 62 tipranavir r 62 ACZ# 62 pharmacologically active isomer 61 epirubicin cyclophosphamide 61 somatostatin analog 61 SUTENT 61 Traficet EN 61 tolvaptan 61 lenalidomide 61 Bendamustine 61 panitumumab 61 metastatic colorectal carcinoma 61 taxane therapy 61 rHuEPO 61 Camptosar ® irinotecan 61 COMBIVIR 61 ixabepilone 61 Fludara ® 61 Xeloda 61 PASI scores 61 Newly Diagnosed Multiple Myeloma 61 enoxaparin 61 Cyclophosphamide 61 resectable 61 paclitaxel Taxol R 61 tumor shrinkage 61 fluconazole 61 irinotecan 61 Mitoxantrone 61 % CI #.#-#.# [003] 61 PROSTVAC ® 61 PSMA ADC 61 vincristine doxorubicin 61 NRTIs 61 G#DT 61 CIMZIA TM certolizumab pegol 61 Filgrastim 61 anti androgen 61 colorectal carcinomas 61 ibandronate 61 TAXOTERE ® 61 PSADT 61 Pioglitazone 61 esomeprazole 61 HCV RESPOND 2 61 T#I [002] 61 miconazole 61 piperacillin tazobactam 61 grade cervical intraepithelial 61 plus ribavirin 61 operable breast cancer 61 #mg dose [001] 61 peginterferon alfa 2a Pegasys 61 BRAF inhibitor 61 dose atorvastatin 61 Anastrozole 61 mTOR inhibitors 61 Amplimexon 61 radiochemotherapy 61 ALND 61 clomipramine 61 HoLEP 61 adjuvant cisplatin 61 lumiliximab 61 severe neutropenia 61 hormone refractory metastatic prostate 61 dutasteride 61 ELACYT 61 TLUS 61 dipyridamole 61 warfarin therapy 61 FOLFOX6 chemotherapy regimen 61 trans retinoic acid 61 sulfasalazine 61 Copegus 61 #:# randomization 61 tamoxifen Nolvadex 61 imatinib 61 cangrelor 61 tapentadol ER 61 KRAS mutant tumors 61 bivalirudin monotherapy 61 colorectal liver metastases 61 EOquin TM 61 ximelagatran 61 pegylated interferons 61 relapsing multiple sclerosis 61 Monotherapy 61 EURIDIS 61 weekly subcutaneous injections 61 GVAX 61 Taxotere R 61 RRMS patients 61 Kaplan Meier 61 HuLuc# 61 selegiline 61 oxcarbazepine 61 PRADAXA 61 RSR# efaproxiral 61 canakinumab 61 concomitant medications 61 nilotinib 61 potent CYP#A# inhibitors 61 conjugated estrogens 61 paroxetine Paxil 61 mcg BID 61 otamixaban 61 tiotropium bromide 61 nephrectomy 61 mcg dose 61 CR CRu 61 relapsed multiple myeloma 61 LMWH 61 Degarelix 61 argatroban 61 tipranavir ritonavir 61 resectable pancreatic cancer 61 Xanafide 61 leuprorelin 61 bexarotene 61 TREANDA 61 paclitaxel poliglumex 61 Randomized Phase 61 Metastatic Renal Cell Carcinoma 61 Tavocept 61 Sprycel dasatinib 61 doripenem 61 Autologous Stem Cell Transplantation 61 Dacogen decitabine 61 Doxil 61 mcg QD 61 evaluating tivozanib 61 lipid lowering agents 61 recurrent VTE 61 brain metastases 61 #mg/day [002] 61 morphometric vertebral fractures 61 Imprime PGG 61 Posaconazole 61 DFMO 61 luteinizing hormone releasing 61 Panitumumab 61 aspirin heparin 61 Aplidin R 61 TO AVOID PREGNANCY WHILE 61 baseline LDH 61 NOXAFIL 61 d4T stavudine Zerit 61 fallopian tube cancers 61 vildagliptin 61 plus COPEGUS 61 LT NS# 61 taxane chemotherapy 61 PREZISTA rtv 61 Follicular Lymphoma 61 -#.# log# 61 Temodar ® 61 lumbar spine BMD 61 AGILECT R 61 DAVANAT 61 plus prednisone prednisolone 61 GOUT 61 nonsmall cell lung cancer 61 ZD# [001] 61 radiotherapy RT 61 QVAR R 61 metformin monotherapy 61 relapsed CLL 61 INCB# [003] 61 Onrigin 61 prostate cancer CRPC 61 invasive candidiasis 61 sirolimus eluting stent 61 cancer mCRC 61 systemic ALCL 61 Genasense 61 NOLVADEX 61 OvaRex MAb 61 treatment naive genotype 61 levetiracetam 61 non squamous NSCLC 61 cytarabine 61 Ceplene/IL-2 61 BAY #-# 61 tranylcypromine 61 8mg/kg 61 celgosivir 61 hematologic toxicity 61 interferon beta 1a 61 NATRECOR ® 61 CYT# QbG# 61 INC# 61 virological failure 61 Aplidin 61 comparator PI r 61 Raptiva r 61 advanced hepatocellular carcinoma 61 abacavir Ziagen 61 noninferior 61 VaD 61 ISEL 61 mertansine 61 metastatic colorectal 61 temozolomide TMZ 61 Fluticasone 61 DAS# CRP 61 ticagrelor 61 EGFR mutation positive 61 zalutumumab 61 Alocrest 61 bortezomib Velcade 61 ARCOXIA 61 relapsed myeloma 61 glatiramer acetate Copaxone 61 KRAS mutation 61 ACUITY trial 61 metastatic gastric 61 chemotherapeutic regimen 61 evaluable patients 61 leukotriene receptor antagonist 61 gemtuzumab ozogamicin 61 anti EGFR antibody 61 medically inoperable 61 Vidaza azacitidine 61 MabCampath 61 LHRH agonist 60 q#h 60 receiving prophylactic anticoagulation 60 Vectibix 60 ribavirin USP 60 antithymocyte globulin 60 sotalol 60 Nilotinib 60 alvespimycin 60 avosentan 60 ALA PDT 60 androgen independent 60 zidovudine lamivudine 60 Helicobacter pylori eradication 60 anthracycline chemotherapy 60 pancreatic adenocarcinoma 60 phase IIb trial 60 mg m² 60 HMG CoA reductase inhibitor 60 FOSRENOL ® 60 EOquin TM phase 60 plus DOXIL 60 methotrexate MTX 60 mitoxantrone plus 60 prospectively defined 60 Mg Uk 60 angiotensin receptor blocker ARB 60 mycophenolic acid 60 cytoreductive surgery 60 peginterferon alpha 2a 60 HER2 positive cancers 60 AROMASIN 60 Median progression 60 moderately emetogenic 60 GRASPA ® 60 pimecrolimus 60 definite stent thrombosis 60 chemotherapy gemcitabine 60 imatinib resistant 60 Radical prostatectomy 60 Caelyx 60 venlafaxine Effexor 60 Temozolomide 60 vidofludimus 60 glimepiride 60 anti TNFs 60 CPOP R 60 TYGACIL 60 ara C 60 Gefitinib 60 IV NSCLC 60 Metastatic Colorectal Cancer 60 TAVR 60 XGEVA 60 sorafenib Nexavar R 60 baminercept 60 Pegasys plus Copegus 60 TMP SMX 60 Adjuvant therapy 60 amifostine 60 NMIBC 60 INTELENCE 60 PREZISTA ritonavir 60 ketorolac 60 dabigatran etexilate 60 paclitaxel chemotherapy 60 pegylated interferon alfa 2a 60 NRTI backbone 60 ziprasidone 60 metformin XR 60 epoetin alfa 60 haematologic 60 #mg/day [001] 60 SCIg 60 Dyloject TM 60 alpha blocker 60 Tipranavir 60 metformin HCl 60 Tumor Response 60 miconazole Lauriad ® 60 infusional 60 PEG interferon 60 nonrandomized 60 febrile neutropenia 60 external beam radiotherapy 60 Docetaxel 60 #mg q8h 60 Non inferiority